As most equities experience a significant sell-off, Palantir's (NYSE: PLTR) share price is standing out, outperforming the ...

Analyst Kyle Mikson CFA of Canaccord Genuity maintained a Buy rating on Quanterix (QTRX – Research Report), with a price target of ...

(NASDAQ:BLUE) traded lower for the fourth straight session as Bank of America and J.P. Morgan downgraded the gene therapy developer after its Q3 2024 results fell short of expectations for ...